In vitro activities of daptomycin, tigecycline, linezolid and eight other antibiotics, alone and in combination, against 41 Staphylococcus spp. clinical isolates from bone and joint infections.
Kuli
B
B
de Barbeyrac
B
B
Dauchy
F A
FA
Dutronc
H
H
Bébéar
C
C
Mégraud
F
F
Dupon
M
M
D000081:Acetamides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001170:Arthritis, Infectious / Q000382:microbiology*; D001842:Bone and Bones / Q000382:microbiology; D017576:Daptomycin / Q000494:pharmacology; D004357:Drug Synergism; D006801:Humans; D007596:Joints / Q000382:microbiology; D000069349:Linezolid; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000031:analogs & derivatives / Q000494:pharmacology; D023303:Oxazolidinones / Q000494:pharmacology; D013203:Staphylococcal Infections / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects*; D000078304:Tigecycline
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000078304:Tigecycline; D008911:Minocycline; D000069349:Linezolid; D017576:Daptomycin